Navigation Links
FDA Warns Against Sale of Sports Supplements in U.S.
Date:4/15/2013

MONDAY, April 15 (HealthDay News) -- Dietary supplements that contain a stimulant called dimethylamylamine (DMAA) pose numerous health risks and are no longer allowed to be sold in the United States, the U.S. Food and Drug Administration has warned.

DMAA -- which is most often used in supplements promising weight loss, muscle-building and improvement of athletic performance -- can increase blood pressure and may lead to cardiovascular problems such as heart attack, shortness of breath and tightening of the chest. The stimulant may be particularly dangerous when used with caffeine, according to the FDA.

The agency has received 60 reports of illnesses and deaths associated with supplements containing DMAA. The incidents included heart problems and nervous system or psychiatric disorders.

However, a report in itself doesn't prove that a product caused a health problem, an agency news release noted.

The FDA sent warning letters to companies that use DMAA in dietary supplements. All but one of the companies have agreed to stop using the ingredient in their products. One company, USPLabs, has not complied. It responded to the warning letter by submitting published studies that the company said challenge the FDA's concerns.

However, the FDA said the studies did not have sufficient information to defend the use of DMAA in dietary supplements. The government agency is finalizing a formal response to USPLabs, according to Daniel Fabricant, director of FDA's division of dietary supplement programs.

As the FDA continues its efforts to get the stimulant off the market, it urges consumers to check labels and avoid any dietary supplements containing DMAA. Consumers need to be aware that the ingredient can be referred to by 10 possible names. These are listed on the FDA's DMAA web page.

More information

The U.S. Food and Drug Administration has more about DMAA.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, April 11, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
2. American Association of Poison Control Centers Warns That Children Act Fast … and So Do Poisons
3. Know Whats in Your Childs Medications, FDA Warns
4. Facebook Likes Leave a Personal Trail, Study Warns
5. Tattoos Can Pose Health Hazards, Doctor Warns
6. Eating Out Can Hurt Heart Health, Expert Warns
7. Law Firm Warns Patients Who Have Received Alleged Defective Smith & Nephew Hip and Knee Replacement Systems
8. Dont Overlook Eating Issues Tied to Autism, Study Warns
9. Beware Fake Flu Treatments, FDA Warns
10. Winter Holds Many Hazards for Seniors, Expert Warns
11. Health Canada Warns on Interaction of Prilosec with Methotrexate: AttorneyOne Informs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Sale of Sports Supplements in U.S.
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: